Abstract: Introduction: Infertility, affecting 10%-15% of global reproductive-age couples, stands as a complex challenge with profound societal ramifications. This study distinctively focuses on scenarios where male infertility is ruled out, emphasizing on exploration of potential female factors in the infertility.
Methodology: The research was conducted from August 2019 to May 2020, which encompasses a cohort of 45 infertile patients undergoing Diagnostic Hysterolaparoscopy (DHL). Recognized as a gold standard tool amalgamating laparoscopy and hysteroscopy, DHL provides a comprehensive visualization, thus causing early diagnosis of the cause of infertility. The study methodically explores demographic intricacies, socioeconomic parameters, and infertility durations, maintaining a balance between primary and secondary infertility cases.
Results: The investigation delves into common menstrual irregularities, ovarian factors, and discerns correlations, particularly with Anti-Mullerian Hormone (AMH). The study accentuates the pivotal role of DHL in unravelling the intricate etiology of infertility. DHL demonstrates a 95% detection rate of abnormalities, DHL emerges as a highly effective diagnostic tool. The research identifies a spectrum of causative factors, with a notable prevalence of ovarian pathologies. Post-DHL intervention, a substantial 28.9% conception rate is observed, coupled with tailored interventions significantly ameliorating patient outcomes.
Conclusion: Diagnostic Hysterolaparoscopy stands out as a cost-effective and efficacious diagnostic modality, significantly increasing the fertility rate within six months post-procedure. This research advocates the application of DHL in both primary and secondary infertility cases, underscoring its pivotal role in the comprehensive and management of infertility.
Indexed in Index Copernicus
